| Type | Title | Date Released | |
|---|---|---|---|
8-K | Aimei Health Technology Co., Ltd. Secures Twenty-Fourth Monthly Extension for Business Combination | ||
8-K/A | SPAC Extends Business Combination Deadline to November 6, 2026, Funded by $34,331 Interest-Free Promissory Note | ||
DEF 14A | Form DEF 14A | ||
PRE 14A | Form PRE 14A | ||
8-K | Aimei Health Technology Co., Ltd. Extends Business Combination Deadline to November 6, 2026 | ||
8-K | Aimei Health Technology Co., Ltd. Extends Business Combination Deadline to October 6, 2026 | ||
8-K | Aimei Health Technology Co., Ltd Receives Nasdaq Deficiency Notices Regarding Market Value Requirements | ||
10-Q | Form 10-Q | ||
SCHEDULE 13G/A | First Trust Capital Management L.P. (Filed by) | ||
8-K | Aimei Health Technology Co., Ltd. Extends Business Combination Deadline to September 6, 2026 | ||
SCHEDULE 13G/A | BERKLEY W R CORP (Filed by) | ||
8-K | Aimei Health Technology Co., Ltd. Terminates Business Combination Agreement with United Hydrogen Group Inc. |